Enlivex Therapeutics Stock Forecast - Daily Balance Of Power

ENLV Stock  USD 0.93  0.09  10.71%   
Enlivex Stock Forecast is based on your current time horizon.
  
At this time, Enlivex Therapeutics' Inventory Turnover is fairly stable compared to the past year. Payables Turnover is likely to climb to 1.06 in 2024, whereas Fixed Asset Turnover is likely to drop 0.85 in 2024. . Common Stock Shares Outstanding is likely to climb to about 19.5 M in 2024, despite the fact that Net Loss is likely to grow to (26.6 M).
On December 29, 2022 Enlivex Therapeutics had Daily Balance Of Power of 0.5741. Balance of Power indicator (or BOP) measures the strength of Enlivex Therapeutics market sensitivity to bulls and bears. It estimates the ability of Enlivex Therapeutics buyers and sellers to push price to an extreme high or extreme low level. As a result, by monitoring Enlivex Therapeutics Balance of Power indicator one can determine a trend of the price direction.
Check Enlivex Therapeutics VolatilityBacktest Enlivex TherapeuticsTrend Details  

Enlivex Therapeutics Trading Date Momentum

On December 30 2022 Enlivex Therapeutics was traded for  3.94  at the closing time. The top price for the day was 3.98  and the lowest listed price was  3.82 . The trading volume for the day was 72.8 K. The trading history from December 30, 2022 was a factor to the next trading day price decrease. The overall trading delta against the next closing price was 2.96% . The overall trading delta against the current closing price is 0.99% .
Balance of Power indicator was created by Igor Livshin to predict asset short term price movements or warning signals. If Balance of Power indicator is trended towards the high of its range it will signify that the bulls are in control. On the other hand when the BOP indicator is moving towards the lows of its range it signifies that the bears are in control. If the indicator move from a high positive range to a lower positive range it signifies that the buying pressure is decreasing. Conversely, if the indicator move from a low negative range to a higher negative range it signifies that the selling pressure is decreasing.
Compare Enlivex Therapeutics to competition

Other Forecasting Options for Enlivex Therapeutics

For every potential investor in Enlivex, whether a beginner or expert, Enlivex Therapeutics' price movement is the inherent factor that sparks whether it is viable to invest in it or hold it better. Enlivex Stock price charts are filled with many 'noises.' These noises can hugely alter the decision one can make regarding investing in Enlivex. Basic forecasting techniques help filter out the noise by identifying Enlivex Therapeutics' price trends.

View Enlivex Therapeutics Related Equities

 Risk & Return  Correlation

Enlivex Therapeutics Technical and Predictive Analytics

The stock market is financially volatile. Despite the volatility, there exist limitless possibilities of gaining profits and building passive income portfolios. With the complexity of Enlivex Therapeutics' price movements, a comprehensive understanding of forecasting methods that an investor can rely on to make the right move is invaluable. These methods predict trends that assist an investor in predicting the movement of Enlivex Therapeutics' current price.

Enlivex Therapeutics Market Strength Events

Market strength indicators help investors to evaluate how Enlivex Therapeutics stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Enlivex Therapeutics shares will generate the highest return on investment. By undertsting and applying Enlivex Therapeutics stock market strength indicators, traders can identify Enlivex Therapeutics entry and exit signals to maximize returns.

Enlivex Therapeutics Risk Indicators

The analysis of Enlivex Therapeutics' basic risk indicators is one of the essential steps in accurately forecasting its future price. The process involves identifying the amount of risk involved in Enlivex Therapeutics' investment and either accepting that risk or mitigating it. Along with some essential techniques for forecasting enlivex stock prices, we also provide a set of basic risk indicators that can assist in the individual investment decision or help in hedging the risk of your existing portfolios.
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential investments, we recommend comparing similar equities with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.
Explore Investing Ideas  

Additional Tools for Enlivex Stock Analysis

When running Enlivex Therapeutics' price analysis, check to measure Enlivex Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Enlivex Therapeutics is operating at the current time. Most of Enlivex Therapeutics' value examination focuses on studying past and present price action to predict the probability of Enlivex Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Enlivex Therapeutics' price. Additionally, you may evaluate how the addition of Enlivex Therapeutics to your portfolios can decrease your overall portfolio volatility.